The Sero-Prevalence of Antibodies to Trypanosoma cruzi in Latin American Refugees and Immigrants to Canada
- 165 Downloads
Background: Chagas’ disease is caused by infection with the protozoan agent Trypanosoma cruzi. An estimated sixteen to eighteen million people are infected in Latin America. Outside of endemic regions, Chagas’ disease may be transmitted through the transfusion of infected blood components, congenital infection and organ transplantation. We sought to determine the sero-prevalence of antibodies to T. cruzi in a community sample of Latin American refugees and immigrants to Canada.
Methods: This was a sero-prevalence study in Latin American refugees and immigrants living in Canada. Eligible subjects were born in South America, Central America or in Mexico. Participants were recruited from a variety of community settings, as well as from medical clinics. Serum was tested by enzyme-linked immunoassay for antibodies to T. cruzi.
Results: A total of 102 participants were enrolled. One sample tested positive for antibodies for T. cruzi. The seroprevalence in our sample was 1.0% (95% CI: 0.2%- 5.3%).
Interpretation: We found a low sero-prevalence of Chagas’ disease in a community sample of Latin American immigrants and refugees. Physicians who treat Latin American immigrants should consider the risk profile and clinical status of the individual in their decision to screen for Chagas’ disease.
KeywordsChagas’ disease Trypanosoma cruzi Sero-prevalence Immigrants and refugees Latin America Canada
Special thanks to Wendy MacQueen, Regional Parasitology Laboratory, Hamilton Regional Laboratory Medicine Program (St. Joseph’s site), Hamilton, Ontario who did all of the serological testing for this study. The study received funding from Health Canada. Dr. Steele is supported by a career scientist award from the Ontario Ministry of Health and Long Term Care and she is supported as a research scholar by the Department of Family and Community Medicine at the University of Toronto.
- 10.World Health Organization: Control of Chagas’ Disease. WHO Technical Report Series, World Health Organization 1991; 811:1–94Google Scholar
- 13.Braschear RJ, Winkler MA, Schur JD, Lee H, Burczak JD, Hall HJ, et al.: Detection of antibodies to Trypanosoma cruzi among blood donors in the southwestern and western United States. I. Evaluation of the sensitivity and specificity of an enzyme immunoassay for detecting antibodies to T. cruzi. Transfusion 1995; 35:213–218CrossRefGoogle Scholar
- 14.Chagas’ Disease: Frequency and geographical distribution. Weekly Epidemiol Rec 1990; 65:257–264Google Scholar
- 15.Statistics Canada: Immigrant population by place of birth for Canada. 2001 CensusGoogle Scholar